When should decision-analytic modeling be used in the economic evaluation of health care?

Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Scott M. Grundy · JAMA · 1993 · 27.9K citations

Medicine, Cardiology, Cardiovascular Pharmacotherapy +12

Infectious Diseases of Humans: Dynamics and Control

Annals of Internal Medicine · 1992 · 8K citations

Veterinary Medicine, Infectious Disease Control, Infectious Diseases +12

Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection

Michael Fried, Mitchell L. Shiffman, K. Rajender Reddy et al. · New England Journal of Medicine · 2002 · 6.4K citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Michael P. Manns, John G. McHutchison, Stuart C. Gordon et al. · The Lancet · 2001 · 6.1K citations

Medicine, Internal Medicine, Pharmacotherapy +17

Markov Models in Medical Decision Making

Frank A. Sonnenberg, J. Robert Beck · Medical Decision Making · 1993 · 2.4K citations

Business, Decision Sciences, Clinical Decision Support +16